Canton of Geneva supports Connect in Pharma 2023 Geneva’s position as a leading European... tinyurl.com/2qz2x9xj tinyurl.com/2qz2x9xj

AstraZeneca’s Tagrisso delivers positive results The company’s phase 3 study showed trea... tinyurl.com/2pnuu9vu tinyurl.com/2pnuu9vu

AeroGo Current Edition To access thi... tinyurl.com/2jgazt8e tinyurl.com/2jgazt8e

Pharmalex Current Edition To access thi... tinyurl.com/2flox7hu tinyurl.com/2flox7hu

It’s All About Stem Cells Current Edition It... tinyurl.com/2fvhmeb4 tinyurl.com/2fvhmeb4

DDL 2023 The Drug Delivery to the Lungs Conferen... tinyurl.com/2pcanap9 tinyurl.com/2pcanap9

Connect in Pharma launches partnerships for global health innovation Sciad Newswire / Connect in Pharma anno... tinyurl.com/2qmocfno tinyurl.com/2qmocfno

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead The European Laboratory Research & ... tinyurl.com/2oos9e96 tinyurl.com/2oos9e96

First patient dosed in pivotal CureVac flu vaccine study Modified influenza vaccine candidates h... tinyurl.com/2n3cqx2g tinyurl.com/2n3cqx2g

Positive opinion for Gilead’s Hepcludex The vital recommendation ensures market... tinyurl.com/2pybzjlj tinyurl.com/2pybzjlj

Endogena finalises enrolment for retinitis pigmentosa trial The treatment is a small molecule that ... tinyurl.com/2pznvl4o tinyurl.com/2pznvl4o

Ginkgo Bioworks, Boehringer Ingelheim partner on breakthrough therapies Ginkgo Bioworks, a Boston-based biotech... tinyurl.com/2qyj25sy tinyurl.com/2qyj25sy

Novavax to reduce workforce by 25% Maryland-based vaccine maker Novavax an... tinyurl.com/2l9yunyt tinyurl.com/2l9yunyt

Roche bets on Zion HER2 brain metastases prospect Roche has acquired the global rights to... tinyurl.com/2qv23ovt tinyurl.com/2qv23ovt

Explore The Latest Trends At PHARMAP 2023 Digital transformation, AI, Big Data an... tinyurl.com/2j7ly58l tinyurl.com/2j7ly58l

VYNE and Tay Therapeutics reach licence agreement The deal involves an oral BET inhibitor... tinyurl.com/2qmm5xcr tinyurl.com/2qmm5xcr

SporeGen and Destiny advance research collaboration The duo has partnered on developing a b... tinyurl.com/2hbkksrn tinyurl.com/2hbkksrn

NICE approves expanded use of Yescarta and Tecartus Kite’s two CAR T-Cell therapies involve... tinyurl.com/2jpuhsah tinyurl.com/2jpuhsah

Positive CHMP opinion for UCB’s bimekizumab Therapy concerns the treatment of adult... tinyurl.com/2namcol2 tinyurl.com/2namcol2

King's College London and Grünenthal join forces to ease pain Duo will collaborate to develop pluripo... tinyurl.com/2p5fradj tinyurl.com/2p5fradj